ArticleMolecular pharmaceutics2022

Intravenous Administration of Scutellarin Nanoparticles Augments the Protective Effect against Cerebral Ischemia-Reperfusion Injury in Rats.

Chang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.